Average levels of GAD65-GADA complexes were significantly elevated (p = 0.002) in SPS patients (median of PCR starting templates, 155; range 21–60180) compared to the control group (median of PCR starting templates, 10; range 4–37) (Fig. 2B, Supplementary table 1). The gene discussed is GAD2; the disease is stiff-person syndrome.